Intas launches Oral Azacitidine for adult patients with Acute Myeloid Leukaemia
With this, it becomes the first company to do so
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
West is committed to bringing more innovative and high-quality injectable solutions and services
Rob Limouze, Director, Product Management, Devices, West Pharmaceutical, shares details about the opportunities and challenges in…
Biocon Biologics insulin manufacturing facility in Malaysia completes USFDA (PAI) inspection
At the conclusion of the inspection, the agency has issued a form 483 with a total of 6 observations across drug substance, drug…
BDR Pharma launches biapenem to treat intra-abdominal, lower respiratory or complicated urinary…
BIAPENEM is launched under the brand name BIAPEN, in addition to their existing vast range of antibiotics
MSF demands newest COVID-19 treatment recommended by WHO must be accessible to all
Regeneron, which produces the two-drug treatment cocktail casirivimab/imdevimab, must ensure affordable pricing and adequate…
Will personal care and hygiene brands, nutraceuticals be the fallback of pharma companies as price…
Reetesh Dhingra, Co-founder, WiZ, explains why pharmaceutical companies are losing their ground and how these are finding solace…
TechInvention claims positive outcomes of its SARS-CoV-2 vaccine
The study showed a two-fold and a 20-fold increase in the IgG titre value (compared to adjuvant control) at a dose of 50 mcg/0.5ml…
Gujarat to get bulk drug park in Jambusar soon
Speaking during a book launch, Pankaj Joshi, Additional Chief Secretary to the state's Chief Minister, said that the state…
US FDA issues Form 483 to Lupin’s Goa plant
The company has received seven observations from the US health regulator
US FDA authorises third dose of Pfizer COVID-19 vaccine for older Americans
The booster dose is to be administered at least six months after completion of the second dose, and the authorisation would…